Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPILOT-HF: Remote Care Strategies for GDMT Optimization in Heart Failure
NCT05734690Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- May 2023
- Primary completion
- May 2025
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of carvedilol, sacubitril + valsartan, tocilizumab in heart failure (HF), sponsored by Brigham and Women's Hospital. Started May 2023; status: completed.
02
Drugs
carvedilolsacubitril + valsartantocilizumab
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05734690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05734690.